Studienlage · Detail
Schaden
GRADE
Niedrig
164 Zitate
Stichproben = 256 Pat.
Dauer2 Jahre nach Psychosebeginn
KontrolleFrühere Konsumenten, die nach…
EndpunktRückfallrisiko
Verblindungn.a.
DesignProspektive Beobachtungsstudie
Cannabinoidvollspektrum
Applikationinhalativ
Kernaussage
Fortgesetzter täglicher Konsum hochpotenten Cannabis nach erstem Psychoseereignis erhöht das Rückfallrisiko signifikant gegenüber Abstinenz.
Zusammenfassung
n=256 Erst-Psychose-Patienten: tägliche Nutzung hochpotenter Cannabis über 24 Monate assoziiert mit erhöhtem Rückfallrisiko (OR=3,28; 95%-KI 1,22–9,18) und häufigeren Rückfällen (IRR=1,77; 95%-KI 0,96–3,25) vs. Abstinente; Absetzen nach Erkrankungsbeginn war mit günstigstem Krankheitsverlauf assoziiert.
P
PopulationPatienten mit erstem Psychoseepisode (18–65 Jahre), n=256, psychiatrische Versorgung in Süd-London
I
InterventionFortgesetzter hochfrequenter Konsum hochpotenten Cannabis (täglich, 24 Monate, Skunk-ähnlich) nach Psychosebeginn
C
KontrolleFrühere Konsumenten, die nach Psychosebeginn aufhörten, sowie andere Konsummuster
O
OutcomeErhöhtes Rückfallrisiko bei täglichem Hochpotenz-Cannabis-Konsum vs. Abstinenz (OR 3,28; 95% CI 1,22–9,18); mehr Rückfälle (IRR 1,77; 95% CI 0,96–3,25); kürzere Zeit bis zum Rückfall (b −0,22; 95% CI −0,40 bis −0,04); intensivere psychiatrische Versorgung (OR 3,16; 95% CI 1,26–8,09)
Vertrauen in die Evidenz
Niedrig
Zweite von vier GRADE-Stufen, die Effektschätzung ist begrenzt verlässlich.
Qualitätsprofil
Größe
★★★★★
Verblindung
—
Effektstärke
Schaden
Zitate / Jahr
★★★★★
Autoren
Teilen
Abstract
<h4>Background</h4>Although cannabis use after a first episode of psychosis has been associated with relapse, little is known about the determinants of this most preventable risk factor for relapse of psychosis. Here we aimed to study whether the effects on outcome vary depending on the type of cannabis consumed and usage pattern.<h4>Methods</h4>In this observational study, we prospectively recruited and followed up patients aged 18-65 years who presented with their first episode of psychosis to psychiatric services in south London, London, UK. Relapse of psychosis within 2 years after onset of psychosis was defined as risk of subsequent admission to hospital. We classified patients into different patterns of cannabis use based on continuity of use after onset of psychosis, potency of cannabis consumed, and frequency of use after the onset of their illness. We used multiple regression analyses (logistic or binominal) to compare the different cannabis use groups and propensity score analysis to validate the results.<h4>Findings</h4>Between April 12, 2002, and July 26, 2013, 256 patients presented with a first episode of psychosis. We did follow-up assessments for these patients until September, 2015. Simple analyses showed that former regular users of cannabis who stopped after the onset of psychosis had the most favourable illness course with regards to relapse. In multiple analysis, continued high-frequency users (ie, daily use in all 24 months) of high-potency (skunk-like) cannabis had the worst outcome, indexed as an increased risk for a subsequent relapse (odds ratio [OR] 3·28; 95% CI 1·22-9·18), more relapses (incidence rate ratio 1·77; 95% CI 0·96-3·25), fewer months until a relapse occurred (b -0·22; 95% CI -0·40 to -0·04), and more intense psychiatric care (OR 3·16; 95% CI 1·26-8·09) after the onset of psychosis.<h4>Interpretation</h4>Adverse effects associated with continued use of cannabis after the onset of a first episode of psychosis depend on the specific patterns of use. Possible interventions could focus on persuading cannabis-using patients with psychosis to reduce use or shift to less potent forms of cannabis.<h4>Funding</h4>National Institute for Health Research (NIHR).
„Was dem Handeln im Weg steht, wird zum Weg.“